Mingbo Zhang

Dr. Mingbo Zhang

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2014 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
MCMing Chu
Ming Chu
RDRan Ding
Ran Ding
ZCZheng-Yun Chu
Zheng-Yun Chu
MZMingbo Zhang
Mingbo Zhang
XLXiao-Yan Liu
Xiao-Yan Liu
Yuedan WangYuedan Wang
Yuedan Wang
Berberine is an isoquinoline alkaloid mainly extracted from Rhizoma Coptidis and has been shown to possess a potent inhibitory activity against bacterial. However, the role of berberine in anti-bacterial action has not been extensively studied.

1 January 2017 in Pharmacognosy Magazine
Verified
Journal Article
Open access
PDF file
MZMingbo Zhang
Mingbo Zhang
TKTingguo Kang
Tingguo Kang
ZXZhili Xu
Zhili Xu
DDDeqiang Dou
Deqiang Dou
XTXiaojun Tao
Xiaojun Tao
Background: Berberine is a natural isoquinoline alkaloid possessing various pharmacological effects, particularly apparent in the treatment of diarrhea, but the underlying mechanism remains unclear. Smooth muscle myosin light-chain kinase (MLCK) plays a crucial role in the smooth muscle relaxation-contraction events, and it is well known that berberine can effectively depress the contraction of smooth muscle. Hence, whether berberine could inhibit MLCK and then depress the smooth muscle contractility might be researched. Objective: The purpose of this study is to investigate the effects of berberine on MLCK. Based on this, the contractility of gastro-intestine, catalysis activity of MLCK, and molecular docking are going to be evaluated. Materials and Methods: The experiment of smooth muscle contraction was directly monitored the contractions of the isolated gastrointestine by frequency and amplitude at different concentration of berberine. The effects of berberine on MLCK were measured in the presence of Ca2+-calmodulin, using the activities of 20 kDa myosin light chain (MLC20) phosphorylation, and myosin Mg2+-ATPase induced by MLCK. The docking study was conducted with expert software in the meantime. Results: The phosphorylation of myosin and the Mg2+-ATPase activity is reduced in the presence of berberine. Moreover, berberine could inhibit the contractibility of isolated gastric intestine smooth muscle. Berberine could bind to the ATP binding site of MLCK through hydrophobic effect and hydrogen bonding according to the docking study. Conclusion: The present work gives a deep insight into the molecular mechanism for the treatment of diarrhea with berberine, i.e., berberine could suppress the contractility of smooth muscle through binding to MLCK and depressing the catalysis activity of MLCK. Abbreviations used: MLCK: Myosin light chain kinase; MLC20: 20 KDa regulating myosin light chain; CaM: Calmodulin.

4 January 2016 in Molecules
Verified
Journal Article
Open access
PDF file
MCMing Chu
Ming Chu
YHYue-Long Hou
Yue-Long Hou
LXLan Xu
Lan Xu
ZCZheng-Yun Chu
Zheng-Yun Chu
MZMingbo Zhang
Mingbo Zhang
YWYue-Dan Wang
Yue-Dan Wang
Nano-TiO2 is widely applied in the automobile exhaust hose reels as a catalyst to reduce oxynitride emissions, including nitric oxide (NO). In the biomedicine field, NO plays an important role in vasodilation and edema formation in human bodies. However, the deswelling activity of nano-TiO2 has not been reported. Here, we demonstrated that nano-TiO2 can significantly degrade the production of NO in LPS-induced RAW264.7 mouse macrophages. Further study indicated that nano-TiO2 exhibited an effect on vascular permeability inhibition, and prevented carrageenan-induced footpad edema. Therefore, we prepared a nano-TiO2 ointment and observed similar deswelling effects. In conclusion, nano-TiO2 might act as a novel deswelling agent related with its degradation of NO, which will aid in our ability to design effective interventions for edema involved diseases.

27 June 2025 in Molecules
Verified
Journal Article
Open access
PDF file
XSXun Yi Sun
Xun Yi Sun
MZMingbo Zhang
Mingbo Zhang
YZYating Zhang
Yating Zhang
YZYu Zheng
Yu Zheng
JLJing Li
Jing Li
YQYang Qu
Yang Qu
This study systematically investigated the inhibitory mechanism of Arctium lappa L. polyphenols (ALP) against human neutrophil elastase (HNE). Molecular docking techniques were employed to predict the binding patterns and inhibition types between polyphenolic components and HNE, complemented by in vitro enzymatic tests to validate inhibitory efficacy. Combination index (CI) analysis was applied to evaluate synergistic effects. Through preliminary in vitro screening, chlorogenic acid, quercetin, and isochlorogenic acid A were identified as key bioactive constituents. Experimental results demonstrated that the half-inhibitory concentration (IC50) of individual compounds against HNE ranged from 46.4 to 203.3 μM, while ALP extract exhibited dose-dependent inhibition (IC50 = 0.99 mg/mL). Drug combination ratios based on individual IC50 values revealed synergistic effects (CI < 1) in chlorogenic acid-quercetin and isochlorogenic acid A-quercetin combinations, whereas antagonism (CI > 1) was observed in chlorogenic acid-isochlorogenic acid A pairs. The molecular docking results predicted that chlorogenic acid and isochlorogenic acid A competitively occupy the same binding site of the target protein (HNE) to exert inhibitory effects, thereby explaining the antagonism produced by their combination. In contrast, quercetin may inhibit HNE with a binding site different from that of chlorogenic acid or isochlorogenic acid A, which accounts for the observed synergistic effects. This study provides the first systematic elucidation of synergistic mechanisms of ALP as natural HNE inhibitors, providing theoretical foundations for developing novel natural HNE inhibitors with potential applications in acute lung injury, COVID-19-associated inflammatory conditions, and chronic inflammatory diseases.

26 February 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
ZZZixuan Zhang
Zixuan Zhang
JLJinhua Long
Jinhua Long
TLTingting Li
Tingting Li
NXNan Xu
Nan Xu
ZXZhili Xu
Zhili Xu
MZMingbo Zhang
Mingbo Zhang
Obesity is one of the major global public health challenges. Pancreatic lipase (PL) is an important target for obesity management as it plays a key role in lipid absorption. However, the clinical application of synthetic PL inhibitors is limited by adverse effects. Previous studies showed that natural products from traditional Chinese medicines (TCMs) is a promising alternative for developing safe PL inhibitors. In this study, we integrated molecular docking, molecular dynamics (MD) simulations, MM/PBSA binding free energy calculations and in vitro enzymatic assays to systematically screen potential PL inhibitors from TCM constituents. Six compounds with docking scores ranging from −9.9 to −9.0 kcal/mol. MD simulations confirmed the structural stability of six ligand−PL complexes via RMSD, radius of gyration (Rg), hydrogen bond and conformational analysis. MM/PBSA calculations revealed the binding free energies of the six compounds to PL ranged from −21.38±0.40 to −13.33±0.58 kcal/mol. In vitro validation showed five of the six compounds exhibited PL inhibitory activity, among which Hydroxygenkwanin (HYD) was the most potent competitive inhibitor (IC₅₀= 0.128±0.009 mM), followed by Atractylenolide I (ATR-I) (IC50 = 0.584±0.031 mM) and Peiminine (PEI) (IC50 = 0.748±0.042 mM). This study validates the efficiency of the integrated in silico and in vitro strategy for screening natural PL inhibitors and provide valuable reference for the development of novel anti-obesity agents or functional food ingredients.